Reaction profile

The FDA adverse-event record for parathyroid disorder nos

Name: Parathyroid disorder NOS - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

28 FDA reports name parathyroid disorder nos, a lower-volume reaction in the CVM extract (VeDDRA 399). Plate stamps and neighbourhood peers follow.

#2031 of 2,481
by report volume (all reactions): 28
reports citing this reaction: 46.4%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Parathyroid disorder NOS has 28 reports now versus 28 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: −0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Parathyroid disorder NOS changes

FDA AER · VeDDRA plate

Code 399 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 28 reports
DEATH-HOT 46.4%
LOWER-Q #2031/2481
PHOTO-FINISH Absence seizure
SPECIES-DOG Dog · 22
DRUG-LEAD Bedinvetmab · 5
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Absence seizure (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Parathyroid disorder NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Parathyroid disorder NOS

Parathyroid disorder NOS: high death-coded share in the FDA AER plate

Signature read: Parathyroid disorder NOS's 46.4% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 28 named reports in the openFDA extract. Death-coded share is upper-third: 13 of 28 reports (46.4% of named reports). Nearest volume peer: Absence seizure (±0 reports). Lead species Dog (22). Lead co-reported drug Bedinvetmab (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 22

Cat 6

Breeds Most Affected

Domestic Shorthair 5

Dog (other) 2

Shih Tzu 2

Siberian Husky 2

Retriever - Golden 2

Terrier - West Highland White 1

Dachshund - Standard Long-haired 1

Bichon Frise 1

Terrier - Scottish 1

Shepherd Dog - German 1

Associated Drugs

Bedinvetmab 5

Spinosad 4

Milbemycin Oxime + Spinosad 4

Trilostane 4

Amoxicillin + Clavulanic Acid 4

Fluid Therapy 3

Carprofen 2

Oclacitinib Maleate 2

Fluralaner Chew Tablets 2

Doxycycline 2

Pradofloxacin 2

Azithromycin 2

Gabapentin 2

Thiabendazole + Dexamethasone + Neomycin 1

Ivermectin 1

Vitamin B12 1

Steroid (Unknown) 1

Chondroitin Sulfate 1

Recombinant Human Insulin 1

Tris-Edta, Otic 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Parathyroid disorder NOS (#2031 of 2,481 by report volume); death-coded 46.4%. PlainBreed reaction plate · death-coded share stamp 46.4% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →